OpGen Inc (OPGN) USD0.01
Sell:$4.77Buy:$4.77
$0.10
(2.05%)
- This stock can be held in a
Stocks and Shares ISA
Fund and Share Account$0.10
(2.05%)$0.10
(2.05%)Company Information
About this company
OpGen, Inc. is a precision medicine company that uses molecular diagnostics and informatics to combat infectious diseases. The Company distributes molecular microbiology solutions that help guide clinicians with more information about life threatening infections to improve patient outcomes and decrease the spread of infections caused by multidrug-resistant microorganisms (MDROs). The Company's product portfolio includes Unyvero Lower Respiratory Tract Panels, Unyvero Urinary Tract Infection Panel, Unyvero System, and Unyvero Resources. The Unyvero LRT panels enable comprehensive detection of the most clinically relevant pathogens and antibiotic resistance markers. The Unyvero Urinary Tract Infection (UTI) panel simultaneously identifies a comprehensive range of pathogens and antibiotic resistance markers associated with urinary tract infections. The Unyvero system uses multiplex PCR technology to simultaneously test for a range of microorganisms and antibiotic resistance markers.
Key people
Key facts
- EPICOPGN
- LocationUnited States
- SectorHealthcare
- IndustryHealthcare Facilities
- ISINUS68373L5057
- Market cap$49.33m
- Employees100
- Shares in issue10.07m
- ExchangeOver The Counter
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.